Skip to content
HowShorted

Verve Therapeutics, Inc. short interest in 2021

In 2021, Verve Therapeutics, Inc.'s disclosed short interest ran from 3.31% of shares outstanding on 13 Aug 2021 to 12.74% on 31 Dec 2021, a change of +9.43 percentage points. The year's high was 12.74% on 31 Dec 2021 and its low 3.31% on 13 Aug 2021, averaging 7.10% across 10 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.60 days on 29 Oct 2021. Full history: Verve Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025

Aggregate net short position time series for Verve Therapeutics, Inc. in 2021

2021 in figures

Start of year
3.31% (13 Aug 2021)
End of year
12.74% (31 Dec 2021)
Change
+9.43 pp
High
12.74% (31 Dec 2021)
Low
3.31% (13 Aug 2021)
Average
7.10%
Highest days to cover
16.60 (29 Oct 2021)
SEC filings marked
4

Every report in 2021

Verve Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
13 Aug 20213.31%5.2410-Q filed, results (8-K)
31 Aug 20213.88%7.19
15 Sep 20213.93%5.12
30 Sep 20214.63%3.02
15 Oct 20216.21%10.33
29 Oct 20216.92%16.60
15 Nov 20217.98%16.0310-Q filed, results (8-K)
30 Nov 20219.66%11.11
15 Dec 202111.75%12.09
31 Dec 202112.74%7.00

See also: Verve Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.